BARNES-JEWISH HOSPITAL
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
About Us
News & Events
Maps & Locations
Contact Us
Google Search
PATIENT AND VISITOR INFORMATION
TREATMENT PROGRAMS
PREVENTION AND SCREENING
RESEARCH
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Home
Treatment Programs
Types of Cancer
Clinical Trial Search Results
Share
Lung Cancer
NCI Information
Our Treatment Approach
Clinical Trials
Support Groups
Effects of Treatment
Assess Your Risk
Patient Stories
Podcasts
Treatment Team
NEW SEARCH
RETURN TO SEARCH RESULTS
Number:
201212027
Principal Investigator:
Waqar, Saiama
Title:
An Open-label, Randomized Phase IIb/III Active Control Study of Second-line HyperAcute®-Lung (tergenpumatucel-L) Immunotherapy versus Docetaxel in Progressive or Relapsed Non-Small Cell Lung Cancer
Phase:
II/III
Disease Site:
Lung
Participating Site(s):
Main Campus
Map and Directions
West County
Map and Directions
Contact:
800-600-3606 or
info@ccadmin.wustl.edu
Description:
The purpose of this study is to assess overall survival of anti-tumor immunization using HyperAcute®-Lung immunotherapy versus Docetaxel in patients with progressed or relapsed non-small cell lung cancer (NSCLC) that have been previously treated.
More Information:
(Links will take you off this web site)
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)